Frailty Index is Associated with Treatment Decisions for Stage I Non-Small Cell Lung Cancer at a High-Burden Safety-Net Hospital.

[1]  D. Wigle,et al.  PL03.06 Lobar or Sub-lobar Resection for Peripheral Clinical Stage IA = 2 cm Non-small Cell Lung Cancer (NSCLC): Results From an International Randomized Phase III Trial (CALGB 140503 [Alliance]) , 2022, Journal of Thoracic Oncology.

[2]  A. Mansfield,et al.  Influence of Sociodemographic Factors on Treatment Decisions in Non-Small-Cell Lung Cancer. , 2020, Clinical lung cancer.

[3]  A. Vickers,et al.  Development and Evaluation of a New Frailty Index for Older Surgical Patients With Cancer , 2019, JAMA network open.

[4]  S. Stokes,et al.  Impact of insurance status on receipt of definitive surgical therapy and posttreatment outcomes in early stage lung cancer , 2018, Surgery.

[5]  M. Berry,et al.  Factors Associated With Treatment of Clinical Stage I Non–Small‐cell Lung Cancer: A Population‐based Analysis , 2018, Clinical lung cancer.

[6]  Percy Lee,et al.  Comparing Outcomes of Patients With Early‐Stage Non–Small‐Cell Lung Cancer Treated With Stereotactic Body Radiotherapy Based on Frailty Status , 2018, Clinical lung cancer.

[7]  Ying Hou,et al.  Use of frailty to predict survival in elderly patients with early stage non-small-cell lung cancer treated with stereotactic body radiation therapy. , 2017, Journal of geriatric oncology.

[8]  R. Dziedzic,et al.  Stage I non-small-cell lung cancer: long-term results of lobectomy versus sublobar resection from the Polish National Lung Cancer Registry† , 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[9]  Ying Hou,et al.  Modified Frailty Index as a Predictor of Overall and Other Cause-Specific Survival in Early-Stage Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy , 2016 .

[10]  D. Boffa,et al.  Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer. , 2016, The Journal of thoracic and cardiovascular surgery.

[11]  G. Colditz,et al.  Treatment Outcomes in Stage I Lung Cancer: A Comparison of Surgery and Stereotactic Body Radiation Therapy , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[12]  W. Weber,et al.  Ratio of Lymph Node to Primary Tumor SUV on PET/CT Accurately Predicts Nodal Malignancy in Non-Small-Cell Lung Cancer. , 2015, Clinical lung cancer.

[13]  M. Elkins,et al.  Postoperative outcomes following preoperative inspiratory muscle training in patients undergoing cardiothoracic or upper abdominal surgery: a systematic review and meta analysis , 2015, Clinical rehabilitation.

[14]  D. Singer,et al.  Evaluating area-based socioeconomic status indicators for monitoring disparities within health care systems: results from a primary care network. , 2015, Health services research.

[15]  D. Boffa,et al.  Predictors of mortality after surgical management of lung cancer in the National Cancer Database. , 2014, The Annals of thoracic surgery.

[16]  M. Berry,et al.  Thoracoscopic Lobectomy Has Increasing Benefit in Patients With Poor Pulmonary Function: A Society of Thoracic Surgeons Database Analysis , 2012, Annals of surgery.

[17]  Amy Y. Chen,et al.  Safety-net burden hospitals and likelihood of curative-intent surgery for non-small cell lung cancer. , 2011, Journal of the American College of Surgeons.

[18]  E. Steyerberg,et al.  Validation of a prognostic model to predict survival after non-small-cell lung cancer surgery. , 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[19]  J. Bradley,et al.  Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. , 2010, The Journal of thoracic and cardiovascular surgery.

[20]  Xianglin L. Du,et al.  Racial disparities and survival for nonsmall‐cell lung cancer in a large cohort of black and white elderly patients , 2009, Cancer.

[21]  G. Silvestri,et al.  Underuse of surgical resection for localized, non-small cell lung cancer among whites and African Americans in South Carolina. , 2008, The Annals of thoracic surgery.

[22]  D. Hellwig,et al.  18F-FDG PET for Mediastinal Staging of Lung Cancer: Which SUV Threshold Makes Sense? , 2007, Journal of Nuclear Medicine.

[23]  Ewout W Steyerberg,et al.  Long-term survival after non-small cell lung cancer surgery: development and validation of a prognostic model with a preoperative and postoperative mode. , 2006, The Journal of thoracic and cardiovascular surgery.

[24]  Robert B Wallace,et al.  Population variations in the initial treatment of non-small-cell lung cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  C B Begg,et al.  Racial differences in the treatment of early-stage lung cancer. , 1999, The New England journal of medicine.

[26]  D. Postma,et al.  Decline of FEV1 by age and smoking status: facts, figures, and fallacies. , 1997, Thorax.

[27]  L V Rubinstein,et al.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. , 1995, The Annals of thoracic surgery.

[28]  W. Bailey,et al.  Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1 , 1994 .

[29]  J. Aerts,et al.  Survival and Treatment of Non-small Cell Lung Cancer Stage I–II Treated Surgically or with Stereotactic Body Radiotherapy: Patient and Tumor-Specific Factors Affect the Prognosis , 2014, Annals of Surgical Oncology.

[30]  P. Bernet,et al.  Healthcare Safety Net in the US , 2014 .